The Calmer Co. International Limited (ASX: CCO) has reported the strongest quarter in its history with Q1 FY26 sales of $2.4 million, up 26% on Q4 FY25 ($1.9m). Growth was broad-based across Australian retail, the USA, and B2B channels, with additional funding commitments to support inventory and expansion.

The Calmer Co. International Limited (ASX: CCO) has capped off an eventful week with two significant developments that speak directly to the company’s dual focus on operational resilience and market expansion.

The Calmer Co. International Limited (ASX: CCO) has delivered a standout FY25 performance, underpinned by strong revenue growth and strategic product expansion. With a preliminary unaudited revenue result exceeding AU$8 million—an 86% increase on FY24—the company continues to gain traction as a leader in the natural relaxation and alcohol-alternative space.  

In a world grappling with stress and sleeplessness, The Calmer Co. International Limited (ASX: CCO) is emerging as a standout in the wellness beverage market. This Brisbane-based company, known for its innovative kava-infused offerings, has just posted a headline-grabbing 104% year-on-year growth in Amazon USA sales, reaching AUD $203,000 in April 2025 alone.